125 related articles for article (PubMed ID: 31639795)
1. Quantitative Pretreatment CT Parameters as Predictors of Tumor Response of Neuroendocrine Tumor Liver Metastasis to Transcatheter Arterial Bland Embolization.
Liu Y; Chen W; Cui W; Liu H; Zhou X; Chen L; Li J; Chen M; Chen J; Wang Y
Neuroendocrinology; 2020; 110(7-8):697-704. PubMed ID: 31639795
[TBL] [Abstract][Full Text] [Related]
2. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
[TBL] [Abstract][Full Text] [Related]
3. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.
Liapi E; Geschwind JF; Vossen JA; Buijs M; Georgiades CS; Bluemke DA; Kamel IR
AJR Am J Roentgenol; 2008 Jan; 190(1):67-73. PubMed ID: 18094295
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.
Shaheen M; Hassanain M; Aljiffry M; Cabrera T; Chaudhury P; Simoneau E; Kongkaewpaisarn N; Salman A; Rivera J; Jamal M; Lisbona R; Khankan A; Valenti D; Metrakos P
HPB (Oxford); 2012 Jan; 14(1):60-6. PubMed ID: 22151453
[TBL] [Abstract][Full Text] [Related]
5. [Arterial embolization of hepatic metastases from neuroendocrine tumors].
Libicher M; Bovenschulte H
Radiologe; 2009 Mar; 49(3):233-41. PubMed ID: 19183927
[TBL] [Abstract][Full Text] [Related]
6. [Safety and efficacy of transarterial embolization combined with octreotide LAR on reducing tumor burden for neuroendocrine tumor liver metastasis].
Liu YM; Lian F; Zhou XF; Chen WC; Liu HK; Yao W; Fan WZ; Li JP; Chen J; Wang Y
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1142-1146. PubMed ID: 31006216
[No Abstract] [Full Text] [Related]
7. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
[TBL] [Abstract][Full Text] [Related]
9. Radioembolization Versus Bland Embolization for Hepatic Metastases from Small Intestinal Neuroendocrine Tumors: Short-Term Results of a Randomized Clinical Trial.
Elf AK; Andersson M; Henrikson O; Jalnefjord O; Ljungberg M; Svensson J; Wängberg B; Johanson V
World J Surg; 2018 Feb; 42(2):506-513. PubMed ID: 29167951
[TBL] [Abstract][Full Text] [Related]
10. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.
Zener R; Yoon H; Ziv E; Covey A; Brown KT; Sofocleous CT; Thornton RH; Boas FE
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):569-576. PubMed ID: 30627774
[TBL] [Abstract][Full Text] [Related]
11. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session.
Bonomo G; Della Vigna P; Monfardini L; Orgera G; Chiappa A; Bianchi PP; Zampino MG; Orsi F
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1372-9. PubMed ID: 22271077
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography.
Yamada S; Fujii T; Suzuki K; Inokawa Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2016 Feb; 45(2):198-203. PubMed ID: 26390421
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.
Peker A; Çiçek O; Soydal Ç; Küçük NÖ; Bilgiç S
Diagn Interv Radiol; 2015; 21(1):54-9. PubMed ID: 25430526
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.
Duan X; Zhou G; Han X; Ren J; Zheng C; Liang H; Feng G
Acta Radiol; 2015 Jan; 56(1):87-96. PubMed ID: 24425792
[TBL] [Abstract][Full Text] [Related]
17. Computed Tomography-Guided Radiofrequency Ablation Following Transcatheter Arterial Embolization in Treatment of Large Hepatic Hemangiomas.
Ji J; Gao J; Zhao L; Tu J; Song J; Sun W
Medicine (Baltimore); 2016 Apr; 95(15):e3402. PubMed ID: 27082617
[TBL] [Abstract][Full Text] [Related]
18. Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis.
Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Bertani E; Guerini-Rocco E; Spada F; Orsi F
Cardiovasc Intervent Radiol; 2016 Jun; 39(6):948-52. PubMed ID: 26714693
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
[No Abstract] [Full Text] [Related]
20. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
